Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
Fabrizio Cantini(Ospedale di Prato Santo Stefano), Delia Goletti(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani)
Cited by 445
Related Papers
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
|Journal of Infection|2020|179
Optimization of the autophagy measurement in a human cell line and primary cells by flow cytometry
|European Journal of Histochemistry|2019|11